RESUMEN
Staphylococcus aureus clonal complex 398 (CC398) isolates cluster into two distinct phylogenetic clades based on single-nucleotide polymorphisms (SNPs) revealing a basal human clade and a more derived livestock clade. The scn and tet(M) genes are strongly associated with the human and the livestock clade, respectively, due to loss and acquisition of mobile genetic elements. We present canonical single-nucleotide polymorphism (canSNP) assays that differentiate the two major host-associated S. aureus CC398 clades and a duplex PCR assay for detection of scn and tet(M). The canSNP assays correctly placed 88 S. aureus CC398 isolates from a reference collection into the human and livestock clades and the duplex PCR assay correctly identified scn and tet(M). The assays were successfully applied to a geographically diverse collection of 272 human S. aureus CC398 isolates. The simple assays described here generate signals comparable to a whole-genome phylogeny for major clade assignment and are easily integrated into S. aureus CC398 surveillance programs and epidemiological studies.
Asunto(s)
Enfermedades de los Animales/diagnóstico , Enfermedades de los Animales/microbiología , Ganado/microbiología , Infecciones Estafilocócicas/veterinaria , Staphylococcus aureus/clasificación , Animales , Genes Bacterianos , Humanos , Filogenia , Polimorfismo de Nucleótido Simple , Staphylococcus aureus/genéticaRESUMEN
Staphylococcus aureus es responsable de un amplio espectro de cuadros clínicos que van desde infecciones en la piel y los tejidos blandos hasta enfermedades sistémicas muy graves que amenazan la vida; tiene gran importancia en la comunidad y está comúnmente implicado en infecciones nosocomiales. Además, un alto porcentaje de individuos está colonizado por S. aureus, lo cual constituye un factor de riesgo para su diseminación. S. aureus tiene gran capacidad de adquirir resistencia a los antimicrobianos y en la actualidad se encuentran cepas resistentes a la mayoría de los antibióticos disponibles; en particular, su resistencia a la meticilina, inicialmente en el ambiente hospitalario (HA-MRSA) y posteriormente en la comunidad (CA-MRSA), ha dificultado aún más el control mundial de este microorganismo. Los estudios de epidemiología molecular han permitido entender mejor las relaciones evolutivas de las cepas y definir el origen de los clones durante brotes epidémicos. En Colombia se sabe poco sobre la epidemiología de S. aureus y aún menos sobre su comportamiento en la comunidad. Por ello, estudios de vigilancia epidemiológica que involucren la tipificación molecular de las cepas permitirán comprender mejor su epidemiología y establecer estrategias más certeras de tratamiento y control.
Staphylococcus aureus is responsible for a wide variety of clinical manifestations ranging from skin and soft tissue infections to severe systemic and life threatening diseases; it is of relevance in the community and is commonly associated with nosocomial infections. Additionally, a high percentage of the population is colonized by S. aureus, which constitutes a risk factor for its dissemination. S. aureus has great capacity to acquire antimicrobial resistance, and currently there are resistant strains to the majority of available antibiotics; in particular, its resistance to methycillin, initially in the hospital environment (Hospital associated methycillin resistant S. aureus, HA-MRSA) and later in the community (Community acquired methycillin resistant S. aureus, CA-MRSA), has made even more difficult the worldwide control of this microorganism. Molecular epidemiological studies have provided a better understanding of the evolutionary relationships of the strains, and the definition of the clonal source during epidemic outbreaks. In Colombia, very little is known about S. aureus epidemiology and even less about its behavior in the community. Therefore, studies based on epidemiological surveillance, involving molecular typing, will lead to a better understanding of its epidemiology, making it possible the design of more assertive control strategies.